Dr. Menon's lab researches the effects of certain genetic variants on kidney scarring (fibrosis), excessive protein loss in urine and kidney function. His lab focuses on mechanisms by which kidney transplants undergo sustained and irreversible damage from the recipient's immune system leading to reduced graft survival. Using bedside-to-bench approaches, the lab aims to identify potential diagnostic and therapeutic strategies to improve kidney transplant outcomes.
Dr. Menon's lab researches the effects of certain genetic variants on kidney scarring (fibrosis), excessive protein loss in urine and kidney function. His lab focuses on mechanisms by which kidney transplants undergo sustained and irreversible damage from the recipient's immune system leading to reduced graft survival. Using bedside-to-bench approaches, the lab aims to identify potential diagnostic and therapeutic strategies to improve kidney transplant outcomes.
Dr. Menon is a physician-scientist appointed as Staff in Kidney Medicine and Heart, Blood & Kidney Research at Cleveland Clinic, and Adjunct Associate Professor at Yale School of Medicine, where he previously served as Director of Research in Kidney Transplantation. He earned his medical degree at Calicut Medical College and completed internal medicine training at PGIMER, Chandigarh and SUNY Upstate Medical University, followed by fellowships in nephrology, transplant nephrology and molecular nephrology research at Mount Sinai. Continuously funded since 2012 by the ASN, AHA, NIH and Department of Defense, his research integrates human genomics with mechanistic studies to understand kidney injury, proteinuria and fibrosis. His contributions include defining the effects of donor–recipient non-HLA genetic mismatches on transplant outcomes, uncovering a novel T-cell role for APOL1 risk variants and elucidating SHROOM3 signaling in kidney disease. Elected to the American Society for Clinical Investigation in 2024, he also serves as a standing member of the NIH/NIAID Transplantation and Autoimmunity study section.
Appointed
2026
Education & Fellowships
Fellowship – Mount Sinai
Molecular Nephrology
Mount Sinai, NY USA
2014
Fellowship – Mount Sinai
Transplant Nephrology
Mount Sinai, NY USA
2013
Fellowship – Mount Sinai
Nephrology
Mount Sinai, NY USA
2012
Residency – State University of New York
Internal Medicine
Syracuse, NY USA
2010
Residency – Post-Graduate Institute of Medical Education and Research (PGIMER)
Internal Medicine
Chandigarh, India
2005
Undergraduate Education – University of Calicut
Bachelor of Medicine, Bachelor of Surgery
Calicut, India
2002
Honors and Recognition
2026: Distinguished Researcher Award, American Society of Nephrology, 2026 – https://www.kidneynews.org/view/journals/kidney-news/18/10/11/article-p32_35.xml
2025: Inducted into the Interurban clinical club (Physician scientist club founded by William Osler in 1905)
2024: Inducted into the American Society of Clinical Investigation (ASCI) – https://data.the-asci.org/controllers/asci/DirectoryController.php?action=profile&entryId=504253
2023: Young Investigator Award, World Transplant Congress (AST/ASTS)
2021: Early Career Researcher Award, International Society of Nephrology, World Congress of Nephrology, Brussels, EU
2020: Basic Science Achievement Award (Career Development), American Society of Transplantation (AST) – https://www.myast.org/blog/2020-achievement-awards-and-research-grant-recipients
2019: Harold and Lamport Golden Clinical Research Award, for tenure track Assistant Professors with “exceptional potential for making significant contributions in their field.” Icahn School of Medicine at Mount Sinai
2017: New Investigator, American Heart Association (AHA) – Council on Kidney and Cardiovascular Disease, Hypertension-Scientific Sessions
2016: Young Investigator, American Heart Association (AHA) – Council on Kidney and Cardiovascular disease, Hypertension-Scientific Sessions
2014: Young Investigator Award, World Transplant Congress (AST+ TTS congress)
2012-14: Ben J. Lipps Fellowship Award, American Society of Nephrology, (ASN Research Fellowship)
2012: Travel Award, American Society of Nephrology
2009: Williams J. Williams Award for “clinical acumen, professionalism and teaching ability” – State University of New York, Syracuse
2009: Best Graduating Resident Award PGY-3, State University of New York, Syracuse, NY
2009: Excellence in Teaching Award PGY-3, University of New York, Syracuse, NY
2008: Excellence in Teaching Award PGY-2, University of New York, Syracuse, NY
2007: Excellence in Teaching Award PGY-1, University of New York, Syracuse, NY
2006: Awarded Medal (first order) by His Excellency, the Vice President of India for #1 ranking in PGIMER Internal Medicine residency program
2003: Ranked #5 in India in the National Postgraduate Medical entrance exam for PGIMER. 5,000 licensed physicians
2001: Ashoka Medal, Department of Surgery, Calicut Medical College, Calicut, India
2000: Dr. T. K. Komalan Nair Memorial Award, Social and Preventative Medicine, Calicut Medical College, Calicut, India
2000: Dr. Vasanthi Menon Memorial Award, Community Medicine, Calicut Medical College, Calicut India
2000: Winner of 13th Indian Association of Pediatrics (IAP) Quiz, Calicut Medical College, Calicut India
Professional Memberships
Member, Scientific Review Committee, Basic Science – The Transplantation Society
Member, Transplantation, Autoimmunity Study Section – NIH Center for Scientific Review
Member – American Society of Transplantation
Member – American Society of Nephrology
Member – Indian Society of Nephrology
Fellow, American College of Physicians
Our research investigates how genetic variation drives kidney injury, proteinuria and fibrosis, integrating human discoveries with mechanistic models and clinical translation. We defined distinct, cell-specific roles for SHROOM3: promoting tubular profibrotic signaling while preserving the podocyte filtration barrier through interactions with FYN that regulate nephrin phosphorylation and the actin cytoskeleton. By dissecting the protein domains responsible for these effects, we aim to target fibrosis while preserving glomerular function. Related studies identified AMPK activation as a podocyte survival mechanism, motivating a randomized clinical trial of metformin in FSGS and investigations into downstream protective pathways, including autophagy. In parallel, human studies and mice expressing human APOL1 risk variants support a previously unrecognized role for variant-carrying T cells in kidney injury and transplant rejection, complementing established kidney–cell mechanisms.
Our transplant genomics program examines how donor–recipient genetic differences beyond HLA influence long-term allograft survival. We demonstrated that genome-wide non-HLA mismatches associate independently with graft loss through early allograft fibrosis, particularly vascular intimal injury. We combine bioinformatic mapping, functional genomics and mouse models of non-MHC mismatches to identify implicated loci and establish their mechanisms. A major focus is the LIMS1–GCC2 region on chromosome 2, where differences in gene regulation may explain associations between donor–recipient mismatches and graft failure. These studies aim to improve transplant risk stratification, inform organ allocation and identify targets for therapies that preserve long-term graft function.
Our overall program uses bedside-to-bench methodology to understand the mechanisms underlying slow kidney graft damage and failure.
Dr. Menon also maintains an active lab in Nephrology at the Yale School of Medicine.
His lab team at Yale includes:
View publications for Madhav Menon, MD
(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Our education and training programs offer hands-on experience at one of the nationʼs top hospitals. Travel, publish in high impact journals and collaborate with investigators to solve real-world biomedical research questions.
Learn More